(Q44719323)

English

Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 December 2017

Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection (English)

1 reference

Europe PubMed Central

5 December 2017

Hepatitis B virus

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Lee CM

1

1 reference

Europe PubMed Central

5 December 2017

Lu SN

2

1 reference

Europe PubMed Central

5 December 2017

Changchien CS

3

1 reference

Europe PubMed Central

5 December 2017

Yeh CT

4

1 reference

Europe PubMed Central

5 December 2017

Hsu TT

5

1 reference

Europe PubMed Central

5 December 2017

Tang JH

6

1 reference

Europe PubMed Central

5 December 2017

Wang JH

7

1 reference

Europe PubMed Central

5 December 2017

Lin DY

8

1 reference

Europe PubMed Central

5 December 2017

Chen CL

9

1 reference

Europe PubMed Central

5 December 2017

Chen WJ

10

1 reference

Europe PubMed Central

5 December 2017

language of work or name

0 references

publication date

1 October 1999

1 reference

Europe PubMed Central

5 December 2017

1 reference

Europe PubMed Central

5 December 2017

86

1 reference

Europe PubMed Central

5 December 2017

7

1 reference

Europe PubMed Central

5 December 2017

1143-1150

1 reference

Europe PubMed Central

5 December 2017

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1143%3A%3AAID-CNCR7%3E3.0.CO%3B2-Z

21 January 2018

Hepatitis C virus infection is associated with the development of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1143%3A%3AAID-CNCR7%3E3.0.CO%3B2-Z

21 January 2018

Absence of a relationship between antibodies to hepatitis C virus and hepatocellular carcinoma in Mozambique

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1143%3A%3AAID-CNCR7%3E3.0.CO%3B2-Z

21 January 2018

Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1143%3A%3AAID-CNCR7%3E3.0.CO%3B2-Z

21 January 2018

A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1143%3A%3AAID-CNCR7%3E3.0.CO%3B2-Z

21 January 2018

Hepatitis C virus infection in Greece and its role in chronic liver disease and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1143%3A%3AAID-CNCR7%3E3.0.CO%3B2-Z

21 January 2018

Hepatitis C virus infection in chronic liver disease and hepatocellular carcinoma in Saudi Arabia

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1143%3A%3AAID-CNCR7%3E3.0.CO%3B2-Z

21 January 2018

Anti‐HCV antibody in Chinese cirrhotic patients with or without hepatocellular carcinoma: Relation to multitransfusion

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1143%3A%3AAID-CNCR7%3E3.0.CO%3B2-Z

21 January 2018

Prevalence of hepatitis C virus antibodies in chronic liver disease and hepatocellular carcinoma patients in India

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1143%3A%3AAID-CNCR7%3E3.0.CO%3B2-Z

21 January 2018

High prevalence of anti-hepatitis C virus antibodies in a Cameroon rural forest area

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1143%3A%3AAID-CNCR7%3E3.0.CO%3B2-Z

21 January 2018

Different viral aetiology of hepatocellular carcinoma between two hepatitis B and C endemic townships in Taiwan.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1143%3A%3AAID-CNCR7%3E3.0.CO%3B2-Z

21 January 2018

Maternal Transmission of Hepatitis B Surface Antigen in Patients with Hepatocellular Carcinoma in Taiwan

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1143%3A%3AAID-CNCR7%3E3.0.CO%3B2-Z

21 January 2018

Seroepidemiology of hepatitis C virus infection in Taiwan

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1143%3A%3AAID-CNCR7%3E3.0.CO%3B2-Z

21 January 2018

Clinical study on primary carcinoma of the liver in Taiwan

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1143%3A%3AAID-CNCR7%3E3.0.CO%3B2-Z

21 January 2018

Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1143%3A%3AAID-CNCR7%3E3.0.CO%3B2-Z

21 January 2018

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1143%3A%3AAID-CNCR7%3E3.0.CO%3B2-Z

21 January 2018

Hepatitis C virus antibodies among risk groups in Spain

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1143%3A%3AAID-CNCR7%3E3.0.CO%3B2-Z

21 January 2018

Prevalence of anti-HCV antibody in blood donors in the Tokyo area

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1143%3A%3AAID-CNCR7%3E3.0.CO%3B2-Z

21 January 2018

Prevalence of hepatitis C in tropical communities: the importance of confirmatory assays

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1143%3A%3AAID-CNCR7%3E3.0.CO%3B2-Z

21 January 2018

Prevalence of antibody to hepatitis C virus among Saudi Arabian children: a community-based study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1143%3A%3AAID-CNCR7%3E3.0.CO%3B2-Z

21 January 2018

Epidemiology of hepatitis C in the West

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1143%3A%3AAID-CNCR7%3E3.0.CO%3B2-Z

21 January 2018

Hepatitis C: and miles to go before we sleep.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1143%3A%3AAID-CNCR7%3E3.0.CO%3B2-Z

21 January 2018

Routes of transmission of hepatitis C virus in an endemic rural area of Japan. Molecular epidemiologic study of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1143%3A%3AAID-CNCR7%3E3.0.CO%3B2-Z

21 January 2018

Detection of a cluster of hepatitis C infections in a renal transplant unit by analysis of sequence variation of the NS5a gene.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1143%3A%3AAID-CNCR7%3E3.0.CO%3B2-Z

21 January 2018

Role of hepatitis C and delta viruses in the termination of chronic hepatitis B surface antigen carrier state: a multivariate analysis in a longitudinal follow-up study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1143%3A%3AAID-CNCR7%3E3.0.CO%3B2-Z

21 January 2018

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1143%3A%3AAID-CNCR7%3E3.0.CO%3B2-Z

21 January 2018

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1143%3A%3AAID-CNCR7%3E3.0.CO%3B2-Z

21 January 2018

Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1143%3A%3AAID-CNCR7%3E3.0.CO%3B2-Z

21 January 2018

Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka Hepatocellular Carcinoma Prevention Study Group.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1143%3A%3AAID-CNCR7%3E3.0.CO%3B2-Z

21 January 2018

Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1143%3A%3AAID-CNCR7%3E3.0.CO%3B2-Z

21 January 2018

The Declining Risk of Post-Transfusion Hepatitis C Virus Infection

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1143%3A%3AAID-CNCR7%3E3.0.CO%3B2-Z

21 January 2018

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1143%3A%3AAID-CNCR7%3E3.0.CO%3B2-Z

21 January 2018

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1143%3A%3AAID-CNCR7%3E3.0.CO%3B2-Z

21 January 2018

Identifiers

10.1002/(SICI)1097-0142(19991001)86:7<1143::AID-CNCR7>3.0.CO;2-Z

1 reference

Europe PubMed Central

5 December 2017

1 reference

Europe PubMed Central

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44719323&oldid=2034561513"